By George R. Siber, Keith P. Klugman, P. Helena Mäkelä
The advance of protein conjugate vaccines opposed to pneumococcal affliction is arguably the best public health and wellbeing success of the recent millennium. This publication describes the improvement of the vaccines, their notable effect on breathing and different pneumococcal infections, and the vaccines' wider influence on public health.
Read or Download Pneumococcal vaccines : the impact of conjugate vaccine PDF
Similar immunology books
Even though the software of human antibodies as clinical therapeutics for melanoma and immune ailments has been well-established, it's only starting to be learned for the therapy of viral infectious illnesses. Polyclonal immunoglobulins have lengthy been used for a few viral illnesses, yet they've got restricted efficiency and ailment scope.
Research of multidirectional immunological responses on the tumor website permits forming a brand new thought of The Tumor Immunoenvironment, that is brought and mentioned within the current booklet with a specific concentrate on the position of immune cells in controlling the tumor microenvironment at diversified phases of melanoma improvement.
Antibodies in mobilephone Biology specializes in a brand new iteration of protocols geared toward the mobilephone biologist. This laboratory handbook beneficial properties structures and methods which are specifically proper for contemporary difficulties. The contributing authors were conscientiously selected for his or her particular services, and feature supplied precise protocols, recipes, and troubleshooting courses in every one bankruptcy.
- Celiac Disease: Methods and Protocols (Methods in Molecular Medicine)
- Cytokine Inhibitors
- Cellular and Molecular Immunology 5th ed
- Oxidative stress, inflammation, and health
- Integration Interaction of Oncologic Growth (Cancer Growth and Progression)
Extra resources for Pneumococcal vaccines : the impact of conjugate vaccine
Gøtzche, and C. Gluud. 1998. The controlled clinical trial turns 100 years: Fibiger’s trial of serum treatment of diphtheria. BMJ 317:1243–1245. 66. Issaeff, B. 1893. Contibution à l’étude de l’immunité acquise contre le pneumocoque. Ann. Inst. Pasteur 7:260– 279. 67. Jacobson, J. W. 1983. Gram’s discovery of his staining technique. J. Infect. 7:97–101. 68. Keefer, C. , F. G. Blake, E. K. Marshall, J. S. Lockwood, and W. B. Wood. 1943. Penicillin treatment of infections. A report of 500 cases. JAMA 122:1217–1224.
J. Med. 107(1A):55S–62S. 122. Trask, J. , C. J. O’Donovan, and D. M. Moore. 1930. Studies of pneumonia in children. I. Mortality, blood cultures, and humoral antibodies in pneumococcus pneumonia. J. Clin. Investig. 8:623–651. 123. Wadsworth, A. K. 1924. Review of recently published reports on the serum treatment of type I pneumonia, to- 17 gether with a report of 445 additional cases. Am. J. Hyg. 4:119–133. 124. Ward, H. , and J. F. Enders. 1933. An analysis of the opsonic and tropic action of normal and immune sera based on experiments with the pneumococcus.
Lister, F. S. 1917. Prophylactic inoculations of man against pneumococcal infections and more particularly against lobar pneumonia. Publ. S. Afr. Inst. Med. Res. 10: 304–322. 74. Long, S. S. 2005. Capsules, clones, and curious events: pneumococcus under ﬁre from polysaccharide conjugate vaccine. Clin. Infect. Dis. 41:30–34. 75. Lord, F. , and R. Heffron. 1936. Lobar Pneumonia and Serum Therapy, with Special Reference to the Massachusetts Pneumonia Study. Commonwealth Fund, New York, NY. 76. Lund, E.